Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
Your search for "nat2" returned 56 TaqMan® Gene Expression Assays
This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second arylamine N-acetyltransferase gene (NAT1) is located near this gene (NAT2). [provided by RefSeq, Jul 2008]
AAC2, AV377607, NAT-2, NAT2, NAT2A, PNAT
(Human) P11245, (Human) O43637, (Human) O60654, (Human) O60655, (Human) Q13146, (Human) Q16697, (Human) Q2MLE4, (Human) Q2MLF5, (Human) Q2MLG8, (Human) Q2MLJ6, (Human) Q2MLK4, (Human) Q2MLK6, (Human) Q2MLN7, (Human) Q6LET4, (Human) Q86XS0, (Human) Q86XS1, (Human) Q96KY8, (Human) Q96T64, (Human) Q96T65, (Human) Q9H220, (Mouse) P50295, (Rat) P50298
|Protocol||Protocol: TaqMan® Gene Expression Assays||PDF, 2349.1 KB|
|App Note||Application Note: TaqMan® Gene Expression Assays Endogenous Controls||PDF, 493.8 KB|
|QRC||QRC: TaqMan® Gene Expression Assays||PDF, 200.9 KB|
|White Paper||Design Process for Gene Expression Assays||PDF, 943.6 KB|
|White Paper||Gene Expression Assay Performance Guarantee||PDF, 481.9 KB|
|White Paper||TaqMan® Assays shipped at ambient temperature retain their quality and stability||PDF, 3255.7 KB|
|Brochure||Understanding Your Shipment||PDF, 3726.3 KB|
|White Paper||Product Stability Study||PDF, 446.0 KB|
|Spreadsheet||Pathogen Assay Information||XLSX, 4231.7 KB|
Please enter the information below and press OK to send your cart to Core Services for purchase.